Facebook
X
LinkedIn
ForwardTo Block or Not to Block: Reconsidering Beta-Blocker Therapy After Myocardial Infarction
This continuing education activity will review emerging literature that reexamines the role of beta blockers after myocardial infarction in the modern era. Many of the landmark trials supporting routine long-term use were conducted before the widespread adoption of reperfusion and contemporary secondary prevention therapies. This activity will explore how newer evidence may influence duration of therapy and patient selection in current practice.
Target Audience
Pharmacist
Learning Objectives
At the conclusion of the activity, participants should be able to:
1. Describe the pathophysiology of myocardial infarction and the historical rationale for beta-blocker use in this population.
2. Discuss the current standard of practice and guideline recommendations for beta-blocker therapy in myocardial infarction.
3. Evaluate recent literature on long-term beta-blocker use in post-MI patients in the modern era of reperfusion and optimized secondary prevention and discuss its implications for clinical practice.
Additional Information
| Attachment | Size |
|---|---|
 Gonsalves Disclosure Slides.pptx | 310.89 KB |
 How to access credits - Code access.doc | 99.5 KB |
This continuing education activity will review emerging literature that reexamines the role of beta blockers after myocardial infarction in the modern era. Many of the landmark trials supporting routine long-term use were conducted before the widespread adoption of reperfusion and contemporary secondary prevention therapies. This activity will explore how newer evidence may influence duration of therapy and patient selection in current practice.
Michelle Gonsalves
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 0.5 contact hours of continuing pharmacy education credit.
Available Credit
- 0.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.